WT
RDY icon

Wilmington Trust’s Dr. Reddy's Laboratories RDY Stock Holding History

Wilmington Trust’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$302K Hold
35,000
– – 0.01% 614
2014
Q1 		$307K Hold
35,000
– – 0.01% 590
2013
Q4 		$287K Buy
+35,000
New +$277K ﹤0.01% 604

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Wilmington Trust's RDY Position: Q2 2014 in Review

Wilmington Trust held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2014 at 35,000 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #614.

Wilmington Trust first reported a position in RDY in Q4 2013 and has held it in 3 quarters since. The position peaked at $307K in Q1 2014. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2014.

  • Wilmington Trust held 35,000 shares of Dr. Reddy's Laboratories worth $302K as of Q2 2014.
  • Wilmington Trust left its Dr. Reddy's Laboratories share count unchanged in Q2 2014.
  • Dr. Reddy's Laboratories made up 0.01% of Wilmington Trust's portfolio in Q2 2014, its #614 holding.
  • Wilmington Trust first reported a position in Dr. Reddy's Laboratories in Q4 2013 and has held it in 3 quarters since.
  • Wilmington Trust's Dr. Reddy's Laboratories position peaked at $307K in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.